A. Sardar Al-Noori, Z. Ali Mohammed, A. Mohammed Salih, S. Sardar Zuhdi, and H. A. Njeeb, “The significance of serum anti- rituximab (anti-CD20 monoclonal antibody) antibodies in treatment response of patients with B- cells malignancy”, Kufa Jour. Bio., vol. 11, no. 2, pp. 8–14, May 2019.